Found: 9
Select item for more details and to access through your institution.
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 11, p. 1825, doi. 10.1007/s00277-014-2126-9
- By:
- Publication type:
- Article
Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 9, p. 1083, doi. 10.1007/s00277-011-1192-5
- By:
- Publication type:
- Article
Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
- Published in:
- Wiener Klinische Wochenschrift, 2018, v. 130, n. 3/4, p. 115, doi. 10.1007/s00508-018-1315-2
- By:
- Publication type:
- Article
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 4, p. 1401, doi. 10.1002/cam4.1980
- By:
- Publication type:
- Article
A case of acute myeloid leukemia (AML) with an unreported combination of chromosomal abnormalities: gain of isochromosome 5p, tetrasomy 8 and unbalanced translocation der(19)t(17;19)(q23;p13).
- Published in:
- Molecular Cytogenetics (17558166), 2013, v. 6, n. 1, p. 1, doi. 10.1186/1755-8166-6-40
- By:
- Publication type:
- Article
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French- American-British and World Health Organization classifications.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0263-4
- By:
- Publication type:
- Article
Azacitidine in patients with WHO-defined AML - Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-32
- By:
- Publication type:
- Article